Multiple sclerosis: In situ evidence for antibody and complement-mediated demyelination

被引:335
|
作者
Storch, MK
Piddlesden, S
Haltia, M
Iivanainen, M
Morgan, P
Lassmann, H
机构
[1] Univ Vienna, Inst Neurol, A-1090 Vienna, Austria
[2] Univ Wales Coll Med, Dept Biochem Med, Cardiff CF4 4XN, S Glam, Wales
[3] Univ Helsinki, Dept Pathol, Helsinki, Finland
[4] Univ Helsinki, Dept Child Neurol, Helsinki, Finland
关键词
D O I
10.1002/ana.410430409
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We describe a case of multiple sclerosis characterized by deposition of immunoglobulin and complement in the areas of active demyelination. This was particularly evident for the C9neo antigen, which is a marker for the activated lyric complement complex and was exclusively deposited in the areas of active myelin destruction. In addition, macrophages in the lesions contained degradation products that were immunoreactive for myelin antigens, immunoglobulins, and C9neo antigen. Destruction of myelin sheaths was associated with incomplete loss of oligodendrocytes in the active areas and reappearance of oligodendrocytes with remyelination in the inactive plaque center.
引用
收藏
页码:465 / 471
页数:7
相关论文
共 50 条
  • [21] Remembering MOG: Autoantibody mediated demyelination in multiple sclerosis?
    Wekerle, H
    NATURE MEDICINE, 1999, 5 (02) : 153 - 154
  • [22] COMPLEMENT-MEDIATED INHIBITION OF SOLID-PHASE ANTIBODY DETECTION (SPAD)
    Fuller, Anne
    Williams, Kevin
    Hurst, Denise
    Konnick, Ketra
    Eckels, David D.
    HUMAN IMMUNOLOGY, 2009, 70 : S19 - S19
  • [23] Antiphospholipid antibody-dependent, complement-mediated platelet destruction.
    Stewart, MW
    Etches, WS
    Gordon, PA
    BLOOD, 1995, 86 (10) : 331 - 331
  • [24] ROLE OF COMPLEMENT IN DEMYELINATION INDUCED INVITRO BY MULTIPLE-SCLEROSIS SERUM
    BRADBURY, K
    APARICIO, SR
    BIRD, CC
    JOURNAL OF PATHOLOGY, 1982, 137 (01): : 76 - 76
  • [25] Complement-mediated kidney diseases
    Poppelaars, Felix
    Thurman, Joshua M.
    MOLECULAR IMMUNOLOGY, 2020, 128 : 175 - 187
  • [26] Complement-Mediated Disorders in Pregnancy
    Chinchilla, Kana Amari
    Vijayan, Madhusudan
    Garcia, Bruna Taveras
    Jim, Belinda
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2020, 27 (02) : 155 - 164
  • [27] EVIDENCE FOR A COMPLEMENT-MEDIATED INHIBITION AND AN ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY OF DERMAL FIBROBLASTS IN ALOPECIA-AREATA
    ABDELNASER, MB
    BLUMEPEYTAVI, U
    ABDELFATAH, A
    ORFANOS, CE
    ACTA DERMATO-VENEREOLOGICA, 1994, 74 (05) : 351 - 354
  • [28] Complement-Mediated Cellular Injury
    Takano, Tomoko
    Elimam, Hanan
    Cybulsky, Andrey V.
    SEMINARS IN NEPHROLOGY, 2013, 33 (06) : 586 - 601
  • [29] Antibody mediated demyelination
    Van der Goes, A
    Breij, ECW
    Kortekaas, M
    Hoekstra, K
    Jongen, PJH
    Dijkstra, CD
    Amor, S
    EARLY INDICATORS, EARLY TREATMENTS, NEUROPROTECTION IN MULTIPLE SCLEROSIS, 2003, : 155 - 161
  • [30] Radiotherapy modulates antibody-induced complement-mediated tumor cell killing
    Liang, Y.
    Huber, P.
    Kirschfink, M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2017, 47 : 155 - 155